Integrated DNA Technologies and Glycon partner in Australia

Published: 30-Apr-2010
Research & Development

Partnership will bring IDT’s market leading products and services to researchers in Australia

Integrated DNA Technologies (IDT) and Glycon Pty Ltd of New South Wales, Australia, are partnering to bring IDT’s market leading products and services to researchers in Australia. IDT is among the world’s most respected manufacturers of custom synthetic oligonucleotides and genes. Glycon will offer Australia’s scientists local sales and technical support of IDT’s products, complementing IDT’s existing global customer care network available by phone, email and web chat.

Glycon brings more than a decade’s experience in Australia’s biotechnology sector, with advanced expertise in both oligonucleotides and genetic research. Australian scientists will be able to work directly with Glycon to take the maximum advantage of IDT’s entire product portfolio of synthetic DNA and RNA oligos, genes and supporting products.

Wendy Scott, executive sales manager of Glycon explains the benefits of this relationship: 'Our experience and knowledge of IDT’s products enables us to provide exceptional customer service and technical expertise. With our background in biomedical science, broad product knowledge base and customer service experience, we can find the most effective solution for all research needs.'

For further information, please visit www.idtdna.com
  • Companies:
  • Integrated DNA Technologies Inc
See more

You may also like

Research & Development

IDT host a webinar on increasing target specificity with CRISPR

Read more
On 16 August Integrated DNA Technologies will host a webinar titled "Increase on-target specificity of CRISPR genome editing using a novel, high-fidelity Cas9 nuclease”

Trending Articles

  1. Roche acquires clinical-stage biopharmaceutical company Poseida Therapeutics Through the merger, Roche will acquire Poseida's allogeneic CAR-T cell therapy portfolio, including pre-clinical and clinical-stage iterations for a range of conditions
  2. Aurobindo Pharma signs $25m respiratory drug development and commercialisation deal with global pharma company The companies will co-develop and commercialise respiratory therapeutics, diversifying Aurobindo's current portfolio
  3. Steritas and argenx join forces to advance steroid-sparing therapeutic development With the help of Steritas' STOX Suite, argenx aims to develop antibody-based therapeutics for immune diseases, potentially allowing patients to move away from chronic steroid usage
  4. Five critical design elements for Pelton wheel turbine flowmeters Titan Enterprises outlines the factors for cost-effective and reliable low-flow measurement
  5. Anton Paar expands Litesizer DIA Series with new models Introducing affordable and advanced solutions for particle analysis

Upcoming event

CPhI Middle East

10–12 December 2024 | Conference | Riyadh, Saudi Arabia See all

You may also like

Research & Development

IDT host a webinar on increasing target specificity with CRISPR

On 16 August Integrated DNA Technologies will host a webinar titled "Increase on-target specificity of CRISPR genome editing using a novel, high-fidelity Cas9 nuclease”
Research & Development

IDT partners with Illumina for NGS library preparation

Leaders in NGS tools collaborate to deliver robust multiplexing capabilities and streamline target enrichment methods
Distribution

IDT appoints LubioScience as distributors in Switzerland

Researchers in Switzerland no longer need to import IDT products – local expertise facilitates ordering
Research & Development

Integrated DNA Technologies acquires oligonucleotide synthesis company ValueGene

Adds new customers with promise to provide seamless support for genomics research
Manufacturing

IDT opens molecular biology research facility in Redwood City

Dr Caifu Chen to lead new product development at California site
Research & Development

IDT offers CRISPR/Cas9 online resource for genome editing

Comprehensive resource pools the latest in the field for newcomers and experts
Manufacturing

IDT opens US$4.7m manufacturing facility in Singapore

Will provide locally manufactured oligonucleotides to researchers in the region
Subscribe now